However, over-reduction of RyR2 expression can also lead to detrimental effects on neuronal function [83,88], therefore, controlling the opening time rather than blocking the function and expression of RyR2 may be a safer way to modulate AD via RyR2. The gene discussed is RYR2; the disease is Alzheimer disease.